192 related articles for article (PubMed ID: 27640074)
1. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
[TBL] [Abstract][Full Text] [Related]
2. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Inzelberg R; Flash S; Friedman E; Azizi E
Ann Neurol; 2016 Dec; 80(6):811-820. PubMed ID: 27761938
[TBL] [Abstract][Full Text] [Related]
4. The burden of rare damaging variants in hereditary atypical parkinsonism genes is increased in patients with Parkinson's disease.
Kim YJ; Lee J; Kim NY; Hong S; Cho YS; Yoon J
Neurobiol Aging; 2021 Apr; 100():118.e5-118.e13. PubMed ID: 33423827
[TBL] [Abstract][Full Text] [Related]
5. A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes.
De Simone P; Bottillo I; Valiante M; Iorio A; De Bernardo C; Majore S; D'Angelantonio D; Valentini T; Sperduti I; Piemonte P; Eibenschutz L; Ferrari A; Carbone A; Buccini P; Paiardini A; Silipo V; Frascione P; Grammatico P
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322357
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.
Dong J; Gao J; Nalls M; Gao X; Huang X; Han J; Singleton AB; Chen H;
Neurobiol Aging; 2014 Jun; 35(6):1512.e5-1512.e10. PubMed ID: 24439955
[TBL] [Abstract][Full Text] [Related]
7. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
[TBL] [Abstract][Full Text] [Related]
8. Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
Rayner JE; Duffy DL; Smit DJ; Jagirdar K; Lee KJ; De'Ambrosis B; Smithers BM; McMeniman EK; McInerney-Leo AM; Schaider H; Stark MS; Soyer HP; Sturm RA
PLoS One; 2020; 15(9):e0238529. PubMed ID: 32966289
[TBL] [Abstract][Full Text] [Related]
9. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
Gudbjartsson DF; Sulem P; Stacey SN; Goldstein AM; Rafnar T; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Sveinsdottir SG; Magnusson V; Lindblom A; Kostulas K; Botella-Estrada R; Soriano V; Juberías P; Grasa M; Saez B; Andres R; Scherer D; Rudnai P; Gurzau E; Koppova K; Kiemeney LA; Jakobsdottir M; Steinberg S; Helgason A; Gretarsdottir S; Tucker MA; Mayordomo JI; Nagore E; Kumar R; Hansson J; Olafsson JH; Gulcher J; Kong A; Thorsteinsdottir U; Stefansson K
Nat Genet; 2008 Jul; 40(7):886-91. PubMed ID: 18488027
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects.
Hu HH; Guedj M; Descamps V; Jouary T; Bourillon A; Ezzedine K; Taieb A; Bagot M; Bensussan A; Saiag P; Grandchamp B; Basset-Seguin N; Soufir N
J Dermatol Sci; 2011 Nov; 64(2):127-33. PubMed ID: 21906913
[TBL] [Abstract][Full Text] [Related]
11. Low-frequency and rare coding variants of NUS1 contribute to susceptibility and phenotype of Parkinson's disease.
Jiang L; Mei JP; Zhao YW; Zhang R; Pan HX; Yang Y; Sun QY; Xu Q; Yan XX; Tan JQ; Li JC; Tang BS; Guo JF
Neurobiol Aging; 2022 Feb; 110():106-112. PubMed ID: 34635350
[TBL] [Abstract][Full Text] [Related]
12. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
Krainc T; Monje MHG; Kinsinger M; Bustos BI; Lubbe SJ
Mov Disord; 2023 Feb; 38(2):185-195. PubMed ID: 36350228
[TBL] [Abstract][Full Text] [Related]
13. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases.
Aoude LG; Gartside M; Johansson P; Palmer JM; Symmons J; Martin NG; Montgomery GW; Hayward NK
Twin Res Hum Genet; 2015 Apr; 18(2):126-33. PubMed ID: 25787093
[TBL] [Abstract][Full Text] [Related]
15. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
[TBL] [Abstract][Full Text] [Related]
16. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
17. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
Artomov M; Stratigos AJ; Kim I; Kumar R; Lauss M; Reddy BY; Miao B; Daniela Robles-Espinoza C; Sankar A; Njauw CN; Shannon K; Gragoudas ES; Marie Lane A; Iyer V; Newton-Bishop JA; Timothy Bishop D; Holland EA; Mann GJ; Singh T; Daly MJ; Tsao H
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29522175
[TBL] [Abstract][Full Text] [Related]
18. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
19. A closer look at evolution: Variants (SNPs) of genes involved in skin pigmentation, including EXOC2, TYR, TYRP1, and DCT, are associated with 25(OH)D serum concentration.
Saternus R; Pilz S; Gräber S; Kleber M; März W; Vogt T; Reichrath J
Endocrinology; 2015 Jan; 156(1):39-47. PubMed ID: 25396269
[TBL] [Abstract][Full Text] [Related]
20. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
